XORTX Therapeutics Inc. (XRTX)
USD 1.12
(-4.27%)
USD 1.12
(-4.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 3.19 Million | 9.86 Million | 2.86 Million | 1.3 Million | 565.96 Thousand | 1.15 Million |
| Selling, General and Administrative Expenses | 3.17 Million | 2.29 Million | 1.58 Million | 1.09 Million | 506.16 Thousand | 795.65 Thousand |
| Research and Development Expenses | 3.2 Million | 6.48 Million | 669.1 Thousand | 277.45 Thousand | 39.89 Thousand | 342.25 Thousand |
| Other Expenses | - | - | - | - | - | -2.63 Million |
| Cost and Expenses | 3.19 Million | 9.86 Million | 2.86 Million | 1.3 Million | 565.96 Thousand | 1.15 Million |
| Operating Income | -6.56 Million | -10.68 Million | -4.13 Million | -1.3 Million | -565.96 Thousand | -1.15 Million |
| Interest Expense | - | - | 4390.52 | 13.51 Thousand | 37.21 Thousand | 22.29 Thousand |
| Income Tax Expense | -0.01 | - | 4390.52 | 13.51 Thousand | 37.21 Thousand | 22.29 Thousand |
| Earnings before Tax | -2.85 Million | -6.98 Million | -1.29 Million | -1.28 Million | -629.57 Thousand | -3.77 Million |
| Net Income | -2.85 Million | -6.98 Million | -1.29 Million | -1.28 Million | -629.57 Thousand | -3.77 Million |
| Earnings Per Share Basic | -1.44 | -4.73 | -1.18 | -1.74 | -1.06 | -6.45 |
| Earnings Per Share Diluted | -1.44 | -4.72 | -1.18 | -1.73 | -1.06 | -6.45 |
| Weighted Average Shares Outstanding | 1.98 Million | 1.47 Million | 1.09 Million | 740 Thousand | 595 Thousand | 585 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.98 Million | 1.47 Million | 1.09 Million | 740.44 Thousand | 595.49 Thousand | 585.04 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -6.46 Million | -10.63 Million | -4.12 Million | -1.28 Million | -546.06 Thousand | -1.13 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 33.04 Thousand | 31.98 Thousand | 25.03 Thousand | - | 16.25 Thousand | 32.44 Thousand |
| Gross Profit | -33.04 Thousand | -31.98 Thousand | -25.03 Thousand | - | -16.25 Thousand | -32.44 Thousand |
| Operating Expenses | 1.46 Million | 1.05 Million | 985.82 Thousand | 3.19 Million | 1.39 Million | 1.76 Million |
| Selling, General and Administrative Expenses | 1.39 Million | 978.45 Thousand | 847.98 Thousand | - | 510.1 Thousand | 722.3 Thousand |
| Research and Development Expenses | 67.66 Thousand | 73.31 Thousand | 137.83 Thousand | - | 569.71 Thousand | 667.91 Thousand |
| Other Expenses | 608.09 Thousand | - | - | - | - | - |
| Cost and Expenses | 1.49 Million | 1.08 Million | 1.01 Million | 3.19 Million | 1.39 Million | 1.76 Million |
| Operating Income | -1.49 Million | -1.08 Million | -1.01 Million | -6.56 Million | -1.38 Million | -1.75 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 1.00 | -2.00 | 2.00 | -0.01 | -59.94 Thousand | -69.81 Thousand |
| Earnings before Tax | 170.03 Thousand | -3 Million | 2.77 Million | -2.85 Million | -1.33 Million | -1.69 Million |
| Net Income | 170.06 Thousand | -3 Million | 2.69 Million | -2.85 Million | -1.33 Million | -1.69 Million |
| Earnings Per Share Basic | 0.06 | -1.24 | 1.38 | - | -0.67 | -0.85 |
| Earnings Per Share Diluted | 0.06 | -1.24 | 1.39 | - | -0.67 | -0.85 |
| Weighted Average Shares Outstanding | 2.9 Million | 2.42 Million | 2.01 Million | 1.98 Million | 1.99 Million | 1.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.9 Million | 2.42 Million | 1.99 Million | 1.98 Million | 1.99 Million | 1.99 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.46 Million | -1.05 Million | -985.82 Thousand | - | -1.37 Million | -1.72 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
CTW
QBIEY
KGF
FLUOROCHEM
VINNY
TUGU